Zhu Ting-Fu, Chu Zhu-Fei, Li Jing-Hua
Department of Pediatrics, Ningbo East LVE Hospital, Ningbo 315000, China.
Department of Pediatrics, Yuyao People's hospital, Yuyao 315400, China.
Zhongguo Zhong Yao Za Zhi. 2016 Jun;41(11):2162-2167. doi: 10.4268/cjcmm20161129.
To observe the effect of tripterygium glycosides combined with Danshen injection on blood coagulation mechanism in children with allergic purpura nephritis, and investigate its treatment efficacy through a randomized controlled study. The results showed that before treatment, there were no significant differences in levels of D-D, APTT, PT, FIB and PLT between treatment group and control group; while after treatment, there were significant differences in levels of D-D, PT, FIB and PLT between two groups, but no difference in level of APTT. The effective rate was 90.38% in treatment group, significantly higher than 79.25% in the control group. There was no significant difference in incidence of adverse reactions between two groups. The results suggested that tripterygium glycosides combined with Danshen injection can enhance treatment efficacy and improve blood coagulation mechanism of children in the treatment of purpura nephritis, with high safety and no adverse effects.
观察雷公藤多苷联合丹参注射液对过敏性紫癜性肾炎患儿凝血机制的影响,并通过随机对照研究探讨其治疗效果。结果显示,治疗前,治疗组与对照组的D-二聚体(D-D)、活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、纤维蛋白原(FIB)及血小板计数(PLT)水平比较,差异无统计学意义;治疗后,两组D-D、PT、FIB及PLT水平比较,差异有统计学意义,但APTT水平差异无统计学意义。治疗组有效率为90.38%,显著高于对照组的79.25%。两组不良反应发生率比较,差异无统计学意义。结果提示,雷公藤多苷联合丹参注射液治疗紫癜性肾炎,可提高治疗效果,改善患儿凝血机制,安全性高,无不良反应。